LAVAL, QC / ACCESS Newswire / March 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified ...

LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives ...

It also includes access to the Zacks Style Scores ... Based in British Columbia, Canada, Bausch Health Companies Inc. develops, manufactures and markets a wide range of branded, generic and ...

Moreover, a positive industry re-rating could make it easier for Bausch + Lomb to access capital markets on favorable terms if needed for future expansions or acquisitions. It may also enhance the ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...

VAUGHAN, Ontario (AP) — VAUGHAN, Ontario (AP) — Bausch + Lomb Corporation (BLCO) on Wednesday reported a loss of $3 million in its fourth quarter. On a per-share basis, the Vaughan, Ontario ...

Revenue Grew 16% as Reported and 17% on a Constant Currency 1 Basis Compared to the Full Year of 2023, with Growth Across All Segments VAUGHAN, Ontario, February 19, 2025--(BUSINESS WIRE)--Bausch ...

LAVAL, QC / ACCESS Newswire / February 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the ...

Bausch + Lomb undertakes no obligation to update ... and in order to assure that all investors have access to similar data, the company has determined that it is appropriate to make this data ...